Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 6|pp. 8155–8176
FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
Back to articleFigure 9(9 of 9)
100%
Figure 9
Figure 9.The methylation of FAM72A/B/D in LUAD. (A–C) The visualization between the methylation level and the FAM72A/B/D expression; (D) The Kaplan-Meier survival of the promoter methylation of FAM72B.